Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients

Pathology Clinical Trial

Official title:

Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04360525
• Other study ID #: 18042020
• Status: Completed
• Start date: January 1, 2020
• Est. completion date: April 18, 2020

Study information

• Verified date: April 2020
• Source: Dr. Ersin Arslan Education and Training Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Sigmoid volvulus is frequently seen in male patients over 60 years old. In the sigmoid volvulus <60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in <60 age groups, it is more likely to be another underlying organic pathology.

Description:

Sigmoid volvulus is frequently seen in male patients over 60 years old. Here, the investigators aimed to investigate the causes of sigmoid volvulus developing in patients under 60 years of age. Patients diagnosed with sigmoid volvulus between 2009 and 2018 were retrospectively screened. The patients were divided into two as under 60 years old and above. The co-morbidity, mortality, morbidity, complications, age and gender data of the patients were analyzed. In the sigmoid volvulus <60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in <60 age groups, it is more likely to be another underlying organic pathology.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 134
• Est. completion date: April 18, 2020
• Est. primary completion date: April 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Sigmoid volvulus patients under the age of 60

• Sigmoid volvulus patients at the age of =60

Exclusion Criteria:

• Lack of data

Related Conditions & MeSH terms

• Intestinal Volvulus
• Pathology

Intervention

Other:
• Reasons
Causes of sigmoid volvulus

Locations

Country	Name	City	State
Turkey	Dr. Ersin Arslan Training and Resource Hospital	Gaziantep

Sponsors (2)

Lead Sponsor	Collaborator
Dr. Ersin Arslan Education and Training Hospital	Inonu University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality	Elderly and young patients mortality	up to three months
Primary	Morbidity	Elderly and young patients morbidity	up to three months